From MarketBeat:



StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating. Other analysts have also given the stock various ratings, with a consensus rating of “Hold” and a consensus price target of $60.00. Sanofi’s stock price on the NASDAQ traded down to $48.74 on Friday, with a market capitalization of $123.29 billion. The company last announced its quarterly earnings results, exceeding analysts’ consensus estimates. A number of hedge funds have bought and sold shares of the stock, with institutional investors and hedge funds owning 10.06% of the company’s stock. Sanofi, a healthcare company, operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. Finally, while Sanofi currently has a “Hold” rating among analysts, top-rated analysts believe that there are five other stocks that are better buys.



Original: Sanofi (NASDAQ:SNY) Stock Rating Lowered by StockNews.com